Related Experiment Video
Updated: Jun 25, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
No Chance to Survive: Mo-CBP3-PepII Synthetic Peptide Acts on Cryptococcus neoformans by Multiple Mechanisms of
Tawanny K B Aguiar1, Felipe P Mesquita2, Nilton A S Neto1
1Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza 60451-970, CE, Brazil.
Abstract:
Multidrug-resistant Cryptococcus neoformans is an encapsulated yeast causing a high mortality rate in immunocompromised patients. Recently, the synthetic peptide Mo-CBP3-PepII emerged as a potent anticryptococcal molecule with an MIC50 at low concentration. Here, the mechanisms of action of Mo-CBP3-PepII were deeply analyzed to provide new information about how it led C. neoformans cells to death. Light and fluorescence microscopies, analysis of enzymatic activities, and proteomic analysis were employed to understand the effect of Mo-CBP3-PepII on C. neoformans cells. Light and fluorescence microscopies revealed Mo-CBP3-PepII induced the accumulation of anion superoxide and hydrogen peroxide in C. neoformans cells, in addition to a reduction in the activity of superoxide dismutase (SOD), ascorbate peroxidase (APX), and catalase (CAT) in the cells treated with Mo-CBP3-PepII. In the presence of ascorbic acid (AsA), no reactive oxygen species (ROS) were detected, and Mo-CBP3-PepII lost the inhibitory activity against C. neoformans. However, Mo-CBP3-PepII inhibited the activity of lactate dehydrogenase (LDH) ergosterol biosynthesis and induced the decoupling of cytochrome c (Cyt c) from the mitochondrial membrane. Proteomic analysis revealed a reduction in the abundance of proteins related to energetic metabolism, DNA and RNA metabolism, pathogenicity, protein metabolism, cytoskeleton, and cell wall organization and division. Our findings indicated that Mo-CBP3-PepII might have multiple mechanisms of action against C. neoformans cells, mitigating the development of resistance and thus being a potent molecule to be employed in the production of new drugs against C. neoformans infections.
Insights
The synthetic peptide Mo-CBP3-PepII effectively kills Cryptococcus neoformans by inducing oxidative stress and disrupting cellular functions. This multi-pronged attack on fungal cells suggests potential for new drug development against resistant infections.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Multidrug-resistant *Cryptococcus neoformans* poses a significant threat to immunocompromised individuals, leading to high mortality rates.
- The synthetic peptide *Mo*-CBP3-PepII has shown potent anticryptococcal activity at low concentrations.
Purpose of the Study:
- To elucidate the detailed mechanisms of action of *Mo*-CBP3-PepII against *Cryptococcus neoformans*.
- To provide insights into how *Mo*-CBP3-PepII induces cell death in *C. neoformans*.
Main Methods:
- Light and fluorescence microscopy were used to observe cellular changes.
- Enzymatic activity assays assessed key enzymes like SOD, APX, CAT, and LDH.
- Proteomic analysis identified alterations in protein abundance.
- Experiments included treatment with ascorbic acid to investigate the role of reactive oxygen species.
Main Results:
- *Mo*-CBP3-PepII induced accumulation of superoxide anion and hydrogen peroxide, while reducing SOD, APX, and CAT activity.
- The peptide's anticryptococcal activity was abolished by ascorbic acid, indicating the crucial role of reactive oxygen species (ROS).
- Inhibition of lactate dehydrogenase (LDH) and ergosterol biosynthesis, along with cytochrome c decoupling from mitochondrial membranes, were observed.
- Proteomic analysis revealed decreased protein levels involved in energy metabolism, DNA/RNA metabolism, pathogenicity, protein metabolism, cytoskeleton, and cell wall organization.
Conclusions:
- *Mo*-CBP3-PepII exhibits multiple mechanisms of action against *C. neoformans*, including ROS generation and disruption of essential cellular processes.
- The multifaceted attack by *Mo*-CBP3-PepII may hinder the development of resistance in *C. neoformans*.
- This peptide represents a promising candidate for the development of novel therapeutic agents against *Cryptococcus neoformans* infections.
Related Concept Videos
Cryptococcal Meningitis
Inhibitors of Gram-positive Cell Wall Synthesis
Antifungal Agents
Clinical Significance of Antibiotic Resistance

